#cancer-screening

#cancer-screening

There is a strong push to lower the age for prostate cancer testing following Sir Chris Hoy's appeal, potentially improving early detection among younger men.

The FDA approved a new blood test for colorectal cancer, simpler than other screening methods, aiming to increase early-stage cancer detection and reduce cancer-related deaths.

Blood test approved by FDA for colorectal cancer detection in individuals aged 45 and older, offering an additional screening option.

Detection limitations: The Shield test may not detect early-stage colorectal cancer and misses 87% of precancerous growths, not replacing a colonoscopy.

State of play: Shield test by Guardant to launch soon with FDA approval, becoming the first blood test for colorectal cancer for average-risk individuals eligible for Medicare coverage.